ClinicalTrials.gov
public full text
Public Domain
The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.
The ECLA PHRI COLCOVID Trial is a simple, pragmatic randomized open controlled trial to test the effects of colchicine on moderate/high-risk hospitalized COVID-19 patients with the aim of reducing mortality and/or new requirement for mechanical ventilation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- To Observe Whether Isoflurane Can Treat COVID-19 Patients#892497
- Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)#915196
- Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)#915642
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19#857730
- EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)#1140133
Record · ID 1008472
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive